DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Eyewear Market 2016-2020” report to their offering. The the global eyewear market is forecast to grow at a CAGR of 7.18% during the period 2016-2020. The report cov…
Uncategorized
Customized cross-linking yields stronger corneal flattening
Customized corneal cross-linking compared well with standard cross-linking in terms of visual acuity but yielded stronger corneal flattening and faster epithelial healing, according to a study.The prospective study included 40 eyes of 40 patients with …
Uncategorized
AMA ratifies ethical guidance on telemedicine, telehealth
The AMA adopted new guidance for the ethical practice of telemedicine at its annual meeting, according to a press release issued by the organization.The guidance, which addresses differences in physicians’ responsibilities between traditional patient i…
Uncategorized
AAFP, ACP, AAP, AMA, others renew call for Congress to lift ban on gun research
In the wake of the deadliest mass shooting in U.S. history, in which 49 people were killed and 53 wounded early Sunday after a gunman opened fire in an Orlando gay nightclub, many medical professional organizations have issued multiple statements not only expressing condolences for victims and their families, but also calling on Congress to lift its 20-year ban on the CDC conducting research into gun violence.In a joint statement, leaders from the American Academy of Family Physicians (AAFP), the American Academy of Pediatrics (AAP), the American College of Physicians (Read more...)
Canon’s Telemedicine Technology Improves Screening for Diabetic Retinopathy (Interviews)
While this editor has often covered digital health within startups and early-stage projects, telemedicine innovation is not just the purview of small companies and healthcare incubators. Since 1976, Canon, Inc., the same multinational corporation that has been making cameras and other imaging devices since 1937, has also been involve (Read more...)
Uncategorized
EV06 ophthalmic solution for presbyopia improves visual outcomes in phase 1/2 study
Presbyopic patients who were treated with EV06 ophthalmic solution showed an improvement in visual outcomes in a phase 1/2 study, Encore Vision announced in a press release. “This clinical trial was designed to confirm or not confirm that topically applied lipoic acid at a concentration of 1.5% could increase the elasticity of the human lens and enhance accommodation,” OSN Chief Medical Editor Richard L. Lindstrom, MD, told Ocular Surgery News.